The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1147
January 6, 2003
View Complete Issue         Table of Contents 2019 
OTC loratadine (Claritin)
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
OTC loratadine (Claritin)
January 6, 2003 (Issue: 1147)
The FDA has approved the marketing of loratadine (Claritin - Schering), a second-generation H1-antihistamine, without a prescription. The drug was also recently approved for OTC use as Alavert (Wyeth) and other generics are...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: OTC loratadine (Claritin)
Article code: 1147b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.